Related Experiment Videos
[Palliative treatment of rectal cancer by the trans-anal approach using a urologic prostatectomy device]
J P Arnaud1, B Debras, G Becouarn
1Service de Chirurgie viscérale, CHU Angers.
Chirurgie; Memoires De L'Academie De Chirurgie
|January 1, 1996
Abstract:
Palliative treatment for patients with rectal carcinoma affect more than 10% of the 8000 cases diagnosed each year in France. Twenty-four patients underwent endoscopic trans-anal resection using a urological resectoscope. The morbidity rate was 18,5% and there were no postoperative deaths. The median hospital stay for the procedure alone was 4 days. Good palliation was obtained in 89% of cases. This simple, minimally invasive and economic method should join palliative treatment for patients with rectal carcinoma beside laser destruction and external beam radiotherapy.